Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2020-08-04 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于公司产品获得CE认证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the CE certification of a product. It contains no financial statements, no detailed financial data, no management discussion, or regulatory filings related to financial performance. It is a short announcement (822 characters) about a product certification and its potential impact on the company. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any financial report. It is a regulatory announcement about product certification, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2020-08-04 Chinese
关于医疗器械产品延续注册的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the renewal registration of medical device products, including registration certificate details and validity periods. It is a regulatory announcement about product registration status issued by the National Medical Products Administration. The document is short (872 characters) and does not contain financial data, earnings, or management discussion. It is not a report or financial filing but a regulatory announcement about product registration. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-07-14 Chinese
2020年半年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2020 semi-annual performance forecast (业绩预告) for the period January 1 to June 30, 2020. It provides estimated financial results, including net profit increases and revenue growth, but explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the 2020 semi-annual financial report. The document is short (1166 characters) and serves as a preliminary earnings forecast rather than a full interim or quarterly report containing actual financial statements. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. H1 2020
2020-07-07 Chinese
公司债券2019年度受托管理事务报告
Audit Report / Information Classification · 95% confidence The document is titled "广州阳普医疗科技股份有限公司公司债券 2019 年度受托管理事务报告" which translates to "Guangzhou Yangpu Medical Technology Co., Ltd. Company Bond 2019 Annual Trustee Management Affairs Report." It is a detailed report prepared by the bond trustee (中信建投证券股份有限公司) about the management and supervision of the company's bonds for the year 2019. The content includes bond overview, trustee duties, issuer's 2019 operating and financial status, use of raised funds, debt repayment ability, credit enhancement mechanisms, execution and effectiveness of guarantees, bond principal and interest repayment status, and other related matters. The document is comprehensive and contains substantive financial data and analysis for the 2019 fiscal year. It is not a simple announcement or a certification letter but a full report on bond trustee management affairs for the year. This fits the category of an Audit Report / Information (AR) as it is a standalone report related to bond trustee management, financial status, and compliance, but not a full annual report (10-K) of the company. It is not an earnings release or interim report, nor a regulatory filing or announcement. Therefore, the best classification is AR with high confidence. FY 2019
2020-06-30 Chinese
关于公司债券的临时受托管理事务报告
Audit Report / Information Classification · 95% confidence The document is titled as a '临时受托管理事务报告' which translates to 'Interim Trustee Management Affairs Report' related to company bonds issued by Guangzhou Yangpu Medical Technology Co., Ltd. It is prepared by the bond trustee (CITIC Securities) and discusses bond issuance details, bond trustee responsibilities, and changes in the company's board and supervisory committee members. The document references regulatory approvals and bond issuance specifics but does not contain full financial statements or comprehensive financial performance data. It is a report related to bond trustee management activities rather than a full annual or interim financial report. Given the nature of the document as a trustee management report on company bonds, it fits best under the category of Audit Report / Information (AR), which includes standalone audit or trustee reports and related regulatory information excluding full annual reports. The document length is 2280 characters, which is short but contains substantive content, not just an announcement or certification. Therefore, the classification is AR with high confidence. Q2 2020
2020-06-24 Chinese
中证鹏元关于关注公司董事会、监事会成员变更超过三分之一的公告
Board/Management Information Classification · 95% confidence The document is an announcement from a credit rating agency about changes in the board of directors and supervisory board members of Guangzhou Yangpu Medical Technology Co., Ltd. It details the election results and changes in board composition, emphasizing that the changes exceed one-third of the members. There is no financial report, earnings data, or detailed management discussion. The document focuses on board and supervisory changes, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is MANG with high confidence.
2020-06-19 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.